Vertex Pharma Tops Q1 EPS by 4c; Reiterates Outlook
- ByInvesting.com-
Vertex Pharma (NASDAQ:VRTX) reported Q1 EPS of $3.52, $0.04 better than the analyst estimate of $3.48. Revenue for the quarter came in at $2.1 billion versus the consensus estimate...